证券记录 · 已归档季度
GILD
Gilead Sciences, Inc. · Healthcare · Drug Manufacturers - General
20被追踪持有人
0Δ持有人
255.31M持有股份
$28.60B报告持仓市值
+0新建仓位
−0清仓
动量输入（同类管理人）： 持有人广度 0.0% · 股份流向 -5.6% · 净新建仓位 0.0% · 公式
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q1 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 6 | +1 | 5.67M | $830.55M | +1 | n/a |
| Q2 2026 | 175 | +1 | 941.63M | $119.04B | +5 | −3 |
| Q1 2026 | 176 | +4 | 930.86M | $129.53B | +6 | −3 |
| Q4 2025 | 171 | 0 | 1.00B | $122.89B | +1 | n/a |
| Q3 2025 | 23 | -1 | 603.99M | $67.03B | n/a | −2 |
| Q2 2025 | 22 | -1 | 560.26M | $62.11B | n/a | −1 |
| Q1 2025 | 20 | 0 | 255.31M | $28.60B | n/a | n/a |
| Q4 2024 | 20 | +1 | 270.33M | $24.97B | +1 | n/a |
| Q3 2024 | 18 | 0 | 213.42M | $17.89B | n/a | n/a |
| Q2 2024 | 18 | n/a | 202.41M | $13.88B | n/a | n/a |
持有人 · Q1 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (被动) | 59.52M | -1.4% | $6.67B | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 2 | Capital World Investors ✦ | 53.55M | -25.3% | $6.00B | 1.0% | ▼ Trim | 4 | SEC ↗ |
| 3 | Dodge & Cox ✦ | 32.69M | -0.8% | $3.66B | 2.1% | ▼ Trim | 4 | SEC ↗ |
| 4 | Geode Capital Management ✦ (被动) | 28.48M | +0.7% | $3.19B | 0.3% | ▲ Add | 4 | SEC ↗ ×2 |
| 5 | Wellington Management ✦ | 27.36M | -23.3% | $3.07B | 0.6% | ▼ Trim | 4 | SEC ↗ ×9 |
| 6 | Norges Bank ✦ (被动) | 19.86M | +2.5% | $2.22B | 0.3% | ▲ Add | 4 | SEC ↗ |
| 7 | T. Rowe Price ✦ | 14.70M | +314.6% | $1.65B | 0.2% | ▲ Add | 4 | SEC ↗ ×2 |
| 8 | Renaissance Technologies ✦ | 5.45M | +2.3% | $610.80M | 0.9% | ▲ Add | 4 | SEC ↗ |
| 9 | Citadel Advisors ✦ | 5.37M | +14.4% | $602.15M | 0.6% | ▲ Add | 4 | SEC ↗ ×2 |
| 10 | Millennium Management ✦ | 2.54M | +271.9% | $284.44M | 0.3% | ▲ Add | 4 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 1.86M | +2.8% | $207.37M | 0.2% | ▲ Add | 4 | SEC ↗ ×6 |
| 12 | Adage Capital Partners ✦ | 1.32M | -23.0% | $147.92M | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 13 | Marshall Wace ✦ | 773.87K | -36.4% | $86.71M | 0.1% | ▼ Trim | 4 | SEC ↗ ×2 |
| 14 | Point72 Asset Management ✦ | 510.74K | -40.4% | $57.23M | 0.2% | ▼ Trim | 4 | SEC ↗ |
| 15 | Bridgewater Associates ✦ | 502.95K | +9.1% | $56.36M | 0.3% | ▲ Add | 4 | SEC ↗ |
| 16 | D. E. Shaw & Co. ✦ | 453.76K | -55.2% | $50.84M | 0.1% | ▼ Trim | 4 | SEC ↗ ×2 |
| 17 | Gotham Asset Management ✦ | 250.99K | -2.0% | $28.12M | 0.2% | ▼ Trim | 4 | SEC ↗ |
| 18 | Arrowstreet Capital ✦ | 53.99K | -61.3% | $6.05M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 19 | Two Sigma Investments ✦ | 43.40K | -81.9% | $4.86M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 20 | Fisher Asset Management ✦ | 6.95K | -34.5% | $778,788 | 0.0% | ▼ Trim | 4 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 1 持有人, 61.30K 股份, $8,543 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Oct 15
Mercier Johanna
Officer · 3.00K 股 · $468,660
Oct 15
Dickinson Andrew D
Officer · 3.00K 股 · $468,660
Sep 15
Mercier Johanna
Officer · 600 股 · $87,174
Sep 15
Mercier Johanna
Officer · 800 股 · $115,566
Sep 15
Mercier Johanna
Officer · 1.60K 股 · $229,907
Sep 15
Dickinson Andrew D
Officer · 3.00K 股 · $435,870
Sep 01
O'Day Daniel Patrick
Officer, Director · 1.60K 股 · $236,014
Sep 01
O'Day Daniel Patrick
Officer, Director · 7.99K 股 · $1.19M
Sep 01
O'Day Daniel Patrick
Officer, Director · 5.41K 股 · $807,856
Aug 26
WELTERS ANTHONY
Director · 6.88K 股 · $1.02M
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q1 2025 ·
方法论 ·
通过API获取此数据